Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NIGMS Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (PAR-27-032)
The PAR-27-032 NIGMS MIRA for Early Stage Investigators funds stable multi-year biomedical research programs for newly independent investigators aligned to the NIGMS mission.
NIGMS Maximizing Investigators' Research Award (MIRA) for Established Investigators (PAR-26-121)
PAR-26-121 is a National Institutes of Health/NIGMS MIRA NOFO for established investigators with a recurring submission cycle in 2026 and 2027.
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) 2026-2029
NIH PA-26-002 funds multi-component grants for U.S.-based institutions that pair domestic research leadership with funded international subprojects, using linked domestic and foreign awards under the PF5 mechanism.
NIH Complement-ARIE NAMs Reduction-to-Practice Challenge (3-Phase, 2025/2026-2027)
The NIH Complement-ARIE challenge supports teams building combinatorial new approach methodologies (NAMs) over a multi-phase route, with up to $7,000,000 in prize funding and phase-based milestone payouts.
NIH HEAL PAR-25-154: Early-Stage Discovery of New Pain Targets in the Understudied Druggable Proteome (R03)
NIH HEAL's R03 NOFO supports one-year, pilot-scale projects to generate preliminary data on understudied pain-related proteins and advance mechanistic leads for future translational work, with applications accepted through several NIH standard cycles in 2026.
NIH Mentored Clinical Scientist Research Career Development Award (K08)
Mentored NIH career development mechanism for clinically trained researchers transitioning toward independent investigation.
NIH NIBIB C3i Validation/Execution 2026: NIH-backed commercialization readiness program for 2026/2027
NIH NIBIB's C3i Validation/Execution offers a 24-week commercialization course with mentoring, where eligible investigators and teams validate and execute market and business plans for early-stage biomedical technologies from NIH-funded projects.
NIH NIBIB eC3i Program - Education 2026: Free 10-Week Biomedical Commercialization Course
The NIH NIBIB eC3i Education program is a free 10-week commercialization curriculum for NIH-funded investigators from selected participating institutes, with an application due date of April 17, 2026.
NIH Oligonucleotide Toxicity (OligoTox) Open Data Challenge
A two-phase NIH prize challenge to generate open in vitro human-system datasets for improving predictive models of oligonucleotide therapeutic toxicity, with Phase 2 submissions open until December 31, 2026.
NIH Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
This NIH PAR-26-116 cooperative agreement supports translational research led by extramural investigators that uses NIH Clinical Center infrastructure through a planned collaboration with NIH intramural investigators.